Loss of CD127 expression links immune activation and CD4+ T cell loss in HIV infection

Trends in Microbiology

Volumn 16, Issue 12, 2008, Pages 567-573

  Kiazyk, Sandra A Koesters ^a,b   Fowke, Keith R ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 7;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL LOSS; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE DRUG DOSE; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION;

EID: 56649124632     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2008.08.011     Document Type: Article

References (61)

1. Sodora D.L., and Silvestri G. Immune activation and AIDS pathogenesis. AIDS 22 (2008) 439-446
2. Appay V., and Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214 (2008) 231-241
3. Sattentau Q.J., and Weiss R.A. The CD4 antigen: physiological ligand and HIV receptor. Cell 52 (1988) 631-633
4. Finkel T.H., et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1 (1995) 129-134
5. Brenchley J.M., et al. HIV disease: fallout from a mucosal catastrophe?. Nat. Immunol. 7 (2006) 235-239
6. Leng Q., et al. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquir. Immune Defic. Syndr. 27 (2001) 389-397
7. Grossman Z., et al. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12 (2006) 289-295
8. Hazenberg M.D., et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95 (2000) 249-255
9. Surh C.D., and Sprent J. Regulation of mature T cell homeostasis. Semin. Immunol. 17 (2005) 183-191
10. Seddon B., and Zamoyska R. Regulation of peripheral T-cell homeostasis by receptor signalling. Curr. Opin. Immunol. 15 (2003) 321-324
11. Fry T.J., and Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174 (2005) 6571-6576
12. Kaech S.M., et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4 (2003) 1191-1198
13. Boutboul F., et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 19 (2005) 1981-1986
14. van Leeuwen E.M., et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 106 (2005) 2091-2098
15. Boyman O., et al. Cytokines and T-cell homeostasis. Curr. Opin. Immunol. 19 (2007) 320-326
16. Mazzucchelli R., and Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7 (2007) 144-154
17. Napolitano L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7 (2001) 73-79
18. Sallusto F., et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004) 745-763
19. Marzo A.L., et al. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6 (2005) 793-799
20. Seder R.A., et al. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8 (2008) 247-258
21. Koesters S.A., et al. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 36 (2006) 336-344
22. Rethi B., et al. Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19 (2005) 2077-2086
23. Paiardini M., et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J. Immunol. 174 (2005) 2900-2909
24. MacPherson P.A., et al. Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 28 (2001) 454-457
25. Mercier F., et al. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets. Clin. Exp. Immunol. 152 (2008) 72-80
26. Dunham R.M., et al. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV Infection. J. Immunol. 180 (2008) 5582-5592
27. Colle J.H., et al. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients-effects of antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 42 (2006) 277-285
28. Moniuszko M., et al. Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques. Virology 356 (2006) 188-197
29. Park J.H., et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21 (2004) 289-302
30. Lanzavecchia A., and Sallusto F. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17 (2005) 326-332
31. Potter S.J., et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J. Virol. 81 (2007) 13904-13915
32. Younes S.A., et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 198 (2003) 1909-1922
33. Letvin N.L., et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312 (2006) 1530-1533
34. Okoye A., et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 204 (2007) 2171-2185
35. Sumpter B., et al. Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J. Immunol. 178 (2007) 1680-1691
36. Sousa A.E., et al. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
37. Albuquerque A.S., et al. Rate of increase in circulating IL-7 and Loss of IL-7R{alpha} expression differ in HIV-1 and HIV-2 infections: two lymphopenic diseases with similar hyperimmune activation but distinct outcomes. J. Immunol. 178 (2007) 3252-3259
38. Marziali M., et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS 20 (2006) 2033-2041
39. Golden-Mason L., et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44 (2006) 1098-1109
40. Boettler T., et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80 (2006) 3532-3540
41. Kim H.R., et al. Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 107 (2006) 2855-2862
42. Sasson S.C., et al. The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr. Drug Targets 7 (2006) 1571-1582
43. Faller E.M., et al. Interleukin-7 receptor expression on CD8 T-cells is downregulated by the HIV Tat protein. J. Acquir. Immune Defic. Syndr. 43 (2006) 257-269
44. Chandele A., et al. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J. Immunol. 180 (2008) 5309-5319
45. Kim H.R., et al. Down-regulation of IL-7Ralpha expression in human T cells via DNA methylation. J. Immunol. 178 (2007) 5473-5479
46. Vranjkovic A., et al. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int. Immunol. 19 (2007) 1329-1339
47. Champagne P., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106-111
48. Hunt P.W., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197 (2008) 126-133
49. Riou C., et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J. Exp. Med. 204 (2007) 79-91
50. Beq S., et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J. Immunol. 176 (2006) 914-922
51. Nikolich-Zugich J. Non-human primate models of T-cell reconstitution. Semin. Immunol. 19 (2007) 310-317
52. Leone, A. et al. (2008) IL-7 immunotherapy and T cell homeostasis in SIV+ ART-treated macaques. In CROI 2008: Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections. URL: http://www.retroconference.org/2008/Abstracts/32992.htm
53. Rosenberg S.A., et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother. 29 (2006) 313-319
54. Sportes C., et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205 (2008) 1701-1714
55. Levy, Y. et al. (2007) Repeated r-hIL-7 doses improve T-cell recovery in HIV-1-infected patients enrolled in a phase I/II multicentric study. In CROI 2007: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections. URL: http://www.retroconference.org/2007/Abstracts/29048.htm
56. th Conference on Retroviruses and Opportunistic Infections. URL: http://www.retroconference.org/2008/Abstracts/31755.htm
57. Sereti, I. et al. (2007) rhIL7 in HIV-1-infected subjects with CD4 T-cell count >100cells/μL and viral load <50,000 copies/mL: results from a randomized, placebo-controlled, double-blinded study (ACTG5214). In CROI 2007: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections. URL: http://www.retroconference.org/2007/Abstracts/28735.htm
58. Alimonti J.B., et al. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J. Infect. Dis. 191 (2005) 20-24
59. Harari A., et al. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174 (2005) 1037-1045
60. Pereyra F., et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197 (2008) 563-571
61. Duvall M.G., et al. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176 (2006) 6973-6981